Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kian Ang

Showing results (161-170 of 206) with videos related to

Pageof 21
Sort By:
Anti-Cancer Drugs|January 25, 2003
Assessment of epidermal growth factor receptor with 99mTc-ethylenedicysteine-C225 monoclonal antibodyNaomi R Schechter, David J Yang, Ali Azhdarinia, et al.
The Lancet. Oncology|November 10, 2009
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survivalJames A Bonner, Paul M Harari, Jordi Giralt, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2015
Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and neckGeorge Shenouda, Qiang Zhang, K Kian Ang, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator systemJerry L Barker, Adam S Garden, K Kian Ang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 27, 2008
The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositisDavid I Rosenthal, Tito R Mendoza, Mark S Chambers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neckAnne S Tsao, Adam S Garden, Merrill S Kies, et al.
Head & Neck|March 16, 2007
Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck moduleDavid I Rosenthal, Tito R Mendoza, Mark S Chambers, et al.
Cancer Research|August 17, 2006
Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinomaChristine H Chung, Joel S Parker, Kim Ely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03Quynh-Thu Le, Jonathan Harris, Anthony M Magliocco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2006
Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13Elizabeth A Elliott, James R Wright, R Suzanne Swann, et al.
Pageof 21

Showing results (161-170 of 206) with videos related to

Sort By:
Pageof 21
Anti-Cancer Drugs|January 25, 2003
Assessment of epidermal growth factor receptor with 99mTc-ethylenedicysteine-C225 monoclonal antibodyNaomi R Schechter, David J Yang, Ali Azhdarinia, et al.
The Lancet. Oncology|November 10, 2009
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survivalJames A Bonner, Paul M Harari, Jordi Giralt, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2015
Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and neckGeorge Shenouda, Qiang Zhang, K Kian Ang, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator systemJerry L Barker, Adam S Garden, K Kian Ang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 27, 2008
The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositisDavid I Rosenthal, Tito R Mendoza, Mark S Chambers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neckAnne S Tsao, Adam S Garden, Merrill S Kies, et al.
Head & Neck|March 16, 2007
Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck moduleDavid I Rosenthal, Tito R Mendoza, Mark S Chambers, et al.
Cancer Research|August 17, 2006
Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinomaChristine H Chung, Joel S Parker, Kim Ely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03Quynh-Thu Le, Jonathan Harris, Anthony M Magliocco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2006
Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13Elizabeth A Elliott, James R Wright, R Suzanne Swann, et al.
Pageof 21